International Clinical Trial: An 8-week, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of HH-204M in vaginal health

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (KCT0012719) titled 'An 8-week, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of HH-204M in vaginal health' on Oct. 1.

Study Type: Interventional Study

Study Design: Primary Purpose : Other(Health functional food), Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT

Primary Sponsor: Hecto Healthcare

Condition:

Diseases of the genitourinary system

Intervention: Dietary Supplement : Study participants will be randomly assigned to either the test group or the control group and will consume one capsule of the test product(H...